On the back of Xylem's (NYSE: XYL) latest quarterly earnings report, investors eagerly traded out of the stock on the second-to-last trading day of the week. This news-fueled decline left the ...

These showed only marginal improvement in revenue and profitability. Xylem's third quarter saw the water technology specialist earn $2.1 billion in revenue, which was 1% higher on a year-over-year ...

Traditional methodologies in this domain, however, often fall short in fully capitalizing on the extensive prior knowledge of brain tissue, typically approaching the task merely as an anomaly ...

Scientists are closing in on ways to help patients grow new heart muscle after a heart attack, as well as new lung tissue to treat fibrosis, corneas to erase eye pain and other body parts to gain ...

Unfortunately for shareholders, while the Xylem Inc. (NYSE:XYL) share price is up 63% in the last five years, that's less than the market return. Some buyers are laughing, though, with an increase ...